Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001806540-24-000002
Filing Date
2024-05-23
Accepted
2024-05-23 12:58:24
Documents
1
Effectiveness Date
2024-05-23
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9490
  Complete submission text file 0001806540-24-000002.txt   10586
Mailing Address 400 EAST JAMIE COURT, SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT, SUITE 200 SOUTH SAN FRANCISCO CA 94080 (650) 686-8821
Lycia Therapeutics, Inc. (Filer) CIK: 0001806540 (see all company filings)

EIN.: 843860514 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-514102 | Film No.: 24976967